Related Experiment Video
Updated: Mar 14, 2026

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats
Published on: February 20, 2021
The Physiology of Early Goal-Directed Therapy for Sepsis
Lindsay Lief1, John Arbo2, David A Berlin1
11 Weill Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
Abstract:
In 2001, Rivers and colleagues published a randomized controlled trial of early goal-directed therapy (EGDT) for the treatment of sepsis. More than a decade later, it remains a landmark achievement. The study proved the benefits of early aggressive treatment of sepsis. However, many questions remain about specific aspects of the complex EGDT algorithm. Recently, 3 large trials attempted to replicate these results. None of the studies demonstrated a benefit of an EGDT protocol for sepsis. This review explores the physiologic basis of goal-directed therapy, including the hemodynamic targets and the therapeutic interventions. An understanding of the physiologic basis of EGDT helps reconcile the results of the clinical trials.
Insights
Early goal-directed therapy (EGDT) for sepsis showed benefits, but recent trials failed to replicate these findings. This review examines the physiologic basis of EGDT to reconcile conflicting clinical trial results.
Area of Science:
- Critical Care Medicine
- Sepsis Pathophysiology
- Clinical Trials
Background:
- Early goal-directed therapy (EGDT) was established as a beneficial sepsis treatment in 2001.
- Despite its initial success, the complex EGDT algorithm has faced scrutiny and replication challenges.
- Recent large trials have failed to demonstrate the benefits of EGDT protocols for sepsis management.
Purpose of the Study:
- To explore the physiologic underpinnings of goal-directed therapy in sepsis.
- To reconcile the conflicting results between the original EGDT trial and subsequent replication attempts.
- To provide a deeper understanding of hemodynamic targets and therapeutic interventions within EGDT.
Main Methods:
- Review of the physiologic basis of goal-directed therapy.
- Analysis of hemodynamic targets and therapeutic interventions in sepsis management.
- Reconciliation of findings from landmark EGDT trials and recent replication studies.
Main Results:
- The original EGDT trial demonstrated significant benefits of early, aggressive sepsis treatment.
- Three subsequent large trials did not find a benefit when using an EGDT protocol for sepsis.
- Understanding the physiology of EGDT is key to interpreting the divergent clinical outcomes.
Conclusions:
- The physiologic rationale for EGDT remains a critical area of study.
- Discrepancies in clinical trial outcomes may stem from variations in protocol implementation or patient populations.
- Further research into the precise mechanisms and optimal application of EGDT is warranted.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Kidney Injury I: Introduction
Acute Kidney Injury VI: Nursing Management

